Katharina Foelsch, Penelope Pelczar, Elisabeth Zierz, Stephanie Kondratowicz, Minyue Qi, Christian Müller, Malik Alawi, Sina Huebener, Till Clauditz, Nicola Gagliani, Samuel Huber, Peter Huebener
BACKGROUND: HMGB1 is a ubiquitous nucleoprotein with immune-regulatory properties following cellular secretion or release in sterile and infectious inflammation. Stool and serum HMGB1 levels correlate with colitis severity and colorectal cancer (CRC) progression, yet recent reports indicated HMGB1 to mainly operate as an intracellular determinant of enterocyte fate during colitis, and investigations into the roles of HMGB1 in CRC are lacking. Using mice with conditional HMGB1-knockout in enterocytes (Hmgb1ΔIEC) and myeloid cells (Hmgb1ΔLysM), respectively, we explored functions of HMGB1 in pathogenetically diverse contexts of colitis and colitis-associated CRC...
January 29, 2024: Journal of Crohn's & Colitis